Last edition
News about "pharmaceutical company "
SK Biopharmaceuticals Secures Global Rights to Biohaven's Opakalim for Epilepsy
SK Biopharmaceuticals will gain exclusive global development and commercialisation rights to opakalim, strengthening its epilepsy portfolio alongside cenobamate and advancing its transition to a multi-product global pharma company.
Pharmaceutical Company | 27/08/2026 | By News Bureau
Qnovia Secures Global License for Novel Antimicrobial Peptide to Combat Drug-Resistant Infections
Qnovia has obtained worldwide exclusive rights from the University of Virginia to develop and commercialise the D8 antimicrobial peptide, a novel therapy designed to target multidrug-resistant bacterial infections through a unique mechanism.
Pharmaceutical Company | 31/07/2026 | By News Bureau
Newron Pharmaceuticals Secures Euro 38 Million to Advance Phase III Schizophrenia Programme
Newron Pharmaceuticals strengthens its funding base with a multi-tranche equity raise to support late-stage development of evenamide in treatment-resistant schizophrenia.
Pharmaceutical Company | 17/02/2026 | By News Bureau | 174
China's NMPA approves Almirall's Seysara for Moderate-to-Severe Acne Treatment
China’s NMPA has approved Almirall’s Seysara (sarecycline hydrochloride), the first oral antibiotic developed specifically for acne, expanding access to innovative dermatology treatment in partnership with Sinomune.
Pharmaceutical Company | 31/01/2026 | By News Bureau | 371
Asston Pharmaceuticals Secures International Supply Order Worth INR 2.65 Crore
Asston Pharmaceuticals has received an order from a leading international pharmaceutical company to supply a range of pharma products worth INR 2.65 crore
Pharmaceutical Company | 02/09/2025 | By Dineshwori | 252
Samsung Bioepis Partners with Harrow for US Commercialisation of Ophthalmology Biosimilars
Following the transition of commercial rights from Biogen back to Samsung Bioepis, Harrow will assume full responsibility for the commercialisation of both BYOOVIZ and OPUVIZ biosimilars in the US.
Pharmaceutical Company | 18/07/2025 | By Dineshwori | 409
Samsung Bioepis Partners with Harrow for US Commercialisation of Ophthalmology Biosimilars
Following the transition of commercial rights from Biogen back to Samsung Bioepis, Harrow will assume full responsibility for the commercialisation of both BYOOVIZ and OPUVIZ biosimilars in the US.
Pharmaceutical Company | 18/07/2025 | By Dineshwori | 409
Eton Pharmaceuticals Announces Acquisition of Galzin
Galzin is FDA-approved as a maintenance treatment of patients with Wilson Disease who have been initially treated with a chelating agent.
Pharmaceutical Company | 04/01/2025 | By Aishwarya | 378
Lupin Gains Approval from FDA for Valbenazine Capsules
Lupin Ltd. has received approval from the US FDA for its Abbreviated New Drug Application (ANDA) for Valbenazine Capsules.
Pharmaceutical Company | 09/04/2024 | By Aishwarya | 1054
We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.
More information: Privacy Policy